Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 20, 2009

Mice Lacking PKC-Alpha Protein Show Lesser Thrombus Formation

  • Mice without the protein PKC-alpha exhibited diminished thrombus formation in vivo but also showed no evidence of overt bleeding, according to investigators at the University of Bristol. They found that PKC-alpha has a major role?in inside-out regulation of bleeding but no significant role in outside-in signaling.

    The ablation of in vitro thrombus formation in certain platelets was rescued by the addition of ADP, consistent with the key mechanistic finding that dense-granule biogenesis and secretion depend upon PKC-alpha expression. Furthermore, defective platelet aggregation in response to either collagen-related peptide or thrombin could be overcome by an increase in agonist concentration. Evidence of overt bleeding including gastrointestinal and tail bleeding was not seen in these mice.

    The researchers thus conclude that the effects of PKC-alpha?ablation on thrombus formation and granule secretion may implicate PKC-alpha??as a drug target for antithrombotic therapy. This article appears online January 19 in the Journal of Clinical Investigation.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »